+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atripla"

HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030 - Product Thumbnail Image

HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030

  • Report
  • May 2023
  • 169 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Atripla - API Insight, 2022 - Product Thumbnail Image

Atripla - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Abacavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Abacavir Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 86 Pages
  • Global
From
HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • November 2023
  • 35 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Atripla is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of three drugs: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. It is taken orally once a day and is used to reduce the amount of HIV in the body, allowing the immune system to recover and preventing further damage. Atripla is one of the most commonly prescribed HIV/AIDS drugs in the United States and is used by millions of people worldwide. Atripla is manufactured by Bristol-Myers Squibb and Gilead Sciences. Other companies that produce HIV/AIDS drugs include GlaxoSmithKline, Merck, and Pfizer. Show Less Read more